IPC To Use PvPi-ADR App

IPC To Use PvPi-ADR App

As part of its ongoing sensitization program on pharmacovigilance methods for reporting adverse events, the Indian Pharmacopoeia Commission (IPC) has advised the pharmacy institutes to mandate the use of PvPI-ADR mobile application by the students for reporting adverse drug reactions (ADRs) to ensure and promote patient safety

Through the “ADR PvPI” mobile application, related images of Adverse Drug-Related and lab reports can be attached in a user-friendly manner for clinical assessment and signal detection as part of pharmacovigilance.

IPC To Use PvPi-ADR App- What is The Mobile Application?

The mobile application is available online. The app has been developed, keeping in mind the patients, consumers, and healthcare professionals.

Indian Pharmacopeia Commission, the National Co-ordinating Centre (NCC) for Pharmacovigilance Programme of India, has developed the android mobile app, which empowers all the health professionals and consumers for ADR reporting.

IPC is an autonomous institution of the ministry of health and family welfare, Government of India. It has been created to set standards of drugs in the country. The mobile application for ADR reporting has also been developed to have administrative control of data with IPC, NCC-PvPI.

This step will empower all the healthcare professionals and patients

for ADR reporting with features like supports source document and image attachment, including consumer reporting, XML generation, and auto-filling of report details to save time.

IPC To Use PvPi-ADR App- What Is The PvPI?

PvPI, which was launched by the Union health ministry, Government of India to report Adverse Drug Reactions towards patients’ safety, has been rapidly growing since its inception in April 2011. Meanwhile, IPC has also been recognized as the WHO collaboration center for pharmacovigilance in public health programs and regulatory services.

An ADR is dangerous when the outcome is death, life-threatening, hospitalization, disability, which can be permanent, congenital anomaly, and requires intervention to prevent permanent impairment or damage.

IPC has generated over 3 lakh ADR data as part of PvPI. The autonomous body has set a mandate to set up a total of 300 AMCs by 2020.

IPC has also been assigned to update information on ADRs that is being reported in India from across all its centers through Vigiflow software to the Uppsala Monitoring Centre (UMC) in Sweden, which is WHO’s collaborating center for international drug monitoring.

Source

Author: Rahul Mishra

LEAVE A REPLY

Please enter your comment!
Please enter your name here